Capula Management’s Bristol-Myers Squibb BMY Stock Holding History

Capula Management’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$4.06M	Buy	67,000 +12,200	+22%	+$711K	0.03%	145
2025 Q4	$2.96M	Buy	54,800 +47,600	+661%	+$2.29M	0.01%	178
2025 Q3	$325K	Buy	7,200 +2,400	+50%	+$112K	﹤0.01%	512
2025 Q2	$222K	Buy	4,800 +800	+20%	+$39.3K	﹤0.01%	351
2025 Q1	$244K	Buy	+4,000	New	+$233K	﹤0.01%	466
2023 Q3	–	Sell	-200,000	Closed	-$12.8M	–	522
2023 Q2	$12.8M	Buy	200,000 +27,600	+16%	+$1.85M	0.31%	44
2023 Q1	$11.9M	Sell	172,400 -141,600	-45%	-$9.99M	0.14%	134
2022 Q4	$22.6M	Buy	314,000 +86,900	+38%	+$6.55M	0.3%	90
2022 Q3	$16.1M	Sell	227,100 -120,400	-35%	-$8.73M	0.22%	125
2022 Q2	$26.8M	Sell	347,500 -2,500	-0.7%	-$190K	0.46%	63
2022 Q1	$25.6M	Buy	+350,000	New	+$23.5M	0.37%	65
2021 Q4	–	Sell	-129,100	Closed	-$7.64M	–	261
2021 Q3	$7.64M	Buy	129,100 +90,000	+230%	+$5.93M	0.09%	178
2021 Q2	$2.59M	Sell	39,100 -9,100	-19%	-$593K	0.04%	266
2021 Q1	$3.04M	Sell	48,200 -162,200	-77%	-$10.1M	0.06%	263
2020 Q4	$13.1M	Buy	+210,400	New	+$12.9M	0.65%	34
2020 Q3	–	Sell	-159,700	Closed	-$9.39M	–	158
2020 Q2	$9.39M	Sell	159,700 -190,300	-54%	-$11.4M	0.33%	75
2020 Q1	$19.5M	Buy	+350,000	New	+$21.4M	0.7%	30

Other funds holding BMY

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Capula Management's BMY Position: Q1 2026 in Review

Capula Management reduced its Bristol-Myers Squibb (BMY) stake by 72% in Q1 2026, selling an estimated $623K and leaving 4,113 shares worth $249K. The position accounts for ﹤0.01% of the portfolio, ranked #689.

Capula Management first reported a position in BMY in Q1 2020 and has held it in 16 quarters since. The position peaked at $16.2M in Q4 2022. 2,517 funds tracked by Wall St. Rank hold BMY as of Q1 2026.

Capula Management held 4,113 shares of Bristol-Myers Squibb worth $249K as of Q1 2026.
Capula Management sold 10,682 Bristol-Myers Squibb shares in Q1 2026, an estimated $623K.
Bristol-Myers Squibb made up ﹤0.01% of Capula Management's portfolio in Q1 2026, its #689 holding.
Capula Management first reported a position in Bristol-Myers Squibb in Q1 2020 and has held it in 16 quarters since.
Capula Management's Bristol-Myers Squibb position peaked at $16.2M in Q4 2022.
2,517 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.

Based on Capula Management's 13F filing for Q1 2026, filed 14 May 2026.